Healthcare

How Is Pediatrix Medical Group (NYSE:MD) Managing Institutional Grow...

Highlights,The New York State Teachers Retirement System increased its stake in Pediatrix Medical Group during the fourth quarter.,Multiple institutio...

How Does Inspire Medical Systems (NYSE:INSP) Compare to Other MedTec...

Highlights,The New York State Teachers Retirement System expanded its holdings in Inspire Medical Systems during the fourth quarter.,Institutional par...

How Is Brookdale Senior Living (NYSE:BKD) Managing Institutional Shi...

Highlights,Major investors, including Allspring Global Investments, significantly reduced their holdings in the fourth quarter.,Market sentiment remai...

How Is Novavax, Inc. (NASDAQ:NVAX) Navigating Market Adjustments

Highlights,Analysts at B. Riley revised Novavax’s fiscal year 2024 earnings projections, lowering the estimated EPS from ($1.41) to ($1.83).,Instituti...

Has Van Eck Associates Corp's Position in Dr. Reddy's Laboratories S...

Headlines,• Van Eck Associates Corp expanded its share count in a leading pharmaceutical company during the recent quarter.,• Several major financial...

Rhumbline Advisers Reduces Holdings in Intra-Cellular Therapies, Inc...

Highlights,Rhumbline Advisers slightly reduced its stake in Intra-Cellular Therapies by 0.4% during the fourth quarter, reflecting minor changes in in...

Principal Securities Inc. Purchases 1,120 Shares of Insmed Incorpora...

Highlights,Principal Securities Inc. increased its stake in Insmed by 55.5% during the fourth quarter, showcasing significant investor interest.,Insme...

Will Shifts in Institutional Positions Transform the Medical Instrum...

Headlines,• Allspring Global Investments Holdings LLC reduced its shareholding in a prominent medical instruments supplier.,• Several established fina...

The State of New Jersey Common Pension Fund D Reduces Its Stake in M...

Highlights,Institutional investors adjust their holdings in Merit Medical Systems during the fourth quarter.,Merit Medical Systems demonstrates steady...

Zacks Research Predicts Sanofi's Earnings for Q2 (NASDAQ:SNY)

Highlights,Zacks Research adjusted its Q2 2025 EPS estimate for Sanofi to $0.93, slightly decreasing from a prior prediction of $0.94.,Sanofi's stock...

Leerink Partners Lowers Owens & Minor Q2 EPS Forecast

Highlights,Multiple analysts have revised their earnings estimates for Owens & Minor, adjusting price targets amid varying ratings.,The company's stoc...

Philips (NYSE: PHG) Announces a Collaboration to Develop Advanced Da...

Highlights,Strategic collaboration between Philips and Mass General Brigham aims to enhance patient care.,The partnership will integrate live healthca...

Why Is Doximity’s Stock Price Surging Without Reason?

Why Is Doximity’s Stock Price Surging Without Reason?

How Does Glaukos Corporation (NYSE:GKOS) Maintain Its Market Positio...

Highlights,Rhumbline Advisers increased its position in Glaukos Corporation, reflecting sustained institutional interest.,Key executives and directors...

How Are Institutional Investors Adjusting Their Positions in DaVita...

Highlights,Rhumbline Advisers adjusted its holdings in DaVita Inc., reducing its stake in the company.,Institutional investors continue to engage with...

How Are Institutional Investors Reshaping Their Positions in Align T...

Highlights,Allworth Financial LP significantly expanded its holdings in Align Technology, increasing its stake by a substantial margin.,Several instit...

How Has Moderna (NASDAQ:MRNA) Performed Against Market Expectations

Highlights,Institutional investors such as Rhumbline Advisers adjusted their stake, reducing shares in the last quarter.,Other financial firms, includ...

How Does Cytokinetics (NASDAQ:CYTK) Compare to Other Biopharmaceutic...

Highlights,Analysts maintain a positive stance on Cytokinetics, reflecting market confidence.,Institutional investors have increased their stakes, rei...

How Has Natera (NASDAQ:NTRA) Performed in Recent Market Trends

Highlights,Rhumbline Advisers adjusted its position in Natera, reducing its holdings by a small percentage while maintaining a significant stake.,Nota...

How Are Market Trends Influencing Halozyme Therapeutics (NASDAQ:HALO...

Highlights,Institutional investors, including Rhumbline Advisers, have increased their holdings in the company.,Strong financial performance reflected...